화학공학소재연구정보센터
Biochemical and Biophysical Research Communications, Vol.326, No.1, 93-99, 2005
NO-donating aspirin inhibits the growth of leukemic Jurkat cells and modulates beta-catenin expression
beta-Catenin has been implicated in leukemic cell proliferation. We compared the effects of aspirin (ASA) and the ortho, meta, and para positional isomers of NO-donating aspirin (NO-ASA) on cell growth and beta-catenin expression in human Jurkat T leukemic cells. Cell growth inhibition was strong: IC50 for p-, o-, and m- were 20 +/- 1.6 (mean +/- SEM), 15 +/- 1.5, and 200 12 PM, respectively, in contrast to that of ASA (3200 +/- 375 muM). The para isomer of NO-ASA degraded beta-catenin in a dose- and time-dependent manner coinciding with increasing expression of activated caspase-3. The caspase inhibitor ZVAD blocked beta-catenin cleavage by p-NO-ASA and partially reversed cell growth inhibition by p-NO-ASA but not that by ASA. A denitrated analog of p-NO-ASA did not degrade beta-catenin indicating the importance of the NO-donating moiety. Our findings suggest that NO-ASA merits further study as an agent against leukemia. (C) 2004 Elsevier Inc. All rights reserved.